Even though stroke presents as a variety of clinical syndromes, neuroimaging is the most
important biomarker to help differentiate between stroke subtypes and assess treatment …

Acute ischaemic stroke is a major public health priority and will become increasingly
relevant to neurologists of the future. The cornerstone of effective stroke care continues to be …

Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Background Recent advances in treatment for stroke give new possibilities for optimizing
outcomes. To deliver these prehospital care needs to become more efficient. Aim To …

Background Traumatic brain injury (TBI) is considered a risk factor for the development of
stroke (Hemorrhagic Stroke and Ischemic Stroke). We performed this systemic review and …

Wake-up strokes (WUS) are strokes with unknown exact time of onset as they are noted on
awakening by the patients. They represent 20% of all ischemic strokes. The …

Objectives To develop and externally validate a machine learning (ML) model based on
diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery (FLAIR) to identify …

Sleep apnea is a well established independent risk factor for stroke that confers an
approximately two-fold increased risk of incident stroke. Sleep apnea is highly prevalent …

Objectives FLAIR-DWI mismatch is an effective method to select eligible wake-up stroke
(WUS) patients for intravenous thrombolysis, but shows limitations in the case of subtle …

Introduction: Intravenous tissue-plasminogen activator (tPA) remains the only approved
systemic reperfusion therapy suitable for most patients presenting timely with acute ischemic …